Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Hcy-thiolactone
2. Homocysteine Thiolactone
3. Homocysteine Thiolactone Hydrochloride
4. Homocysteine Thiolactone Hydrochloride, (+-)-isomer
5. Homocysteine Thiolactone Perchlorate Salt
6. Homocysteine Thiolactone Perchlorate, (s)-isomer
7. Homocysteine Thiolactone, (+-)-isomer
8. Homocysteine Thiolactone, (s)-isomer
9. Homocysteine Thiolactone, Dl
10. Homocysteine-thiolactone
1. 3-aminothiolan-2-one
2. 3-aminodihydrothiophen-2-one
3. 10593-85-8
4. 14007-10-4
5. Dl-3-aminotetrahydro-2-thiophenone
6. (+-)-3-aminodihydro-2(3h)-thiophenone
7. 3-aminodihydro-2(3h)-thiophenone
8. 3-aminodihydrothiophen-2(3h)-one
9. D5h88xf24x
10. 2(3h)-thiophenone, 3-aminodihydro-
11. (+-)-3-amino-2-thiolanon
12. 2(3h)-thiophenone, 3-aminodihydro-, (+-)-
13. Homocysteinthiolacton
14. Homocysteinethiolactone
15. Unii-d5h88xf24x
16. Schembl845868
17. ( -)-3-amino-2-thiolanon
18. Chembl3272518
19. 3-aminotetrahydrothiophene-2-one
20. Dtxsid50863228
21. Bbl028068
22. Homocysteine Thiolactone, Dl-
23. Stl352056
24. ( -)-3-aminotetrahydro-2-thiophenon
25. (+-)-3-aminotetrahydro-2-thiophenon
26. Akos001053243
27. 3-aminotetrahydrothiophen-2-one
28. Sb47031
29. (+/-)-homocysteine Thiolactone
30. Homocysteine Thiolactone [who-dd]
31. (2-oxotetrahydrothiophen-3-yl)amine
32. 2(3h)-thiophenone, 3-aminodihydro-, (3s)-
33. 007h104
34. A906044
35. 2-(carboxymethyl-amino)-4-chloro-benzoicacid
36. Q27276123
37. Butanoic Acid, 2-amino-4-mercapto-, .gamma.-(thio Lactone)
38. Butyric Acid, 2-amino-4-mercapto-, .gamma.-(thio Lactone)
39. C0e89172-3f00-4ba6-9494-6129358d1890
| Molecular Weight | 117.17 g/mol |
|---|---|
| Molecular Formula | C4H7NOS |
| XLogP3 | -0.1 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 3 |
| Rotatable Bond Count | 0 |
| Exact Mass | 117.02483502 g/mol |
| Monoisotopic Mass | 117.02483502 g/mol |
| Topological Polar Surface Area | 68.4 Ų |
| Heavy Atom Count | 7 |
| Formal Charge | 0 |
| Complexity | 93.7 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 1 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Radiation-Protective Agents
Drugs used to protect against ionizing radiation. They are usually of interest for use in radiation therapy but have been considered for other purposes, e.g. military. (See all compounds classified as Radiation-Protective Agents.)
ABOUT THIS PAGE
75
PharmaCompass offers a list of Dl-Homocysteine Thiolactone API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Dl-Homocysteine Thiolactone manufacturer or Dl-Homocysteine Thiolactone supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Dl-Homocysteine Thiolactone manufacturer or Dl-Homocysteine Thiolactone supplier.
PharmaCompass also assists you with knowing the Dl-Homocysteine Thiolactone API Price utilized in the formulation of products. Dl-Homocysteine Thiolactone API Price is not always fixed or binding as the Dl-Homocysteine Thiolactone Price is obtained through a variety of data sources. The Dl-Homocysteine Thiolactone Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Dl-Homocysteine Thiolactone manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Dl-Homocysteine Thiolactone, including repackagers and relabelers. The FDA regulates Dl-Homocysteine Thiolactone manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Dl-Homocysteine Thiolactone API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Dl-Homocysteine Thiolactone supplier is an individual or a company that provides Dl-Homocysteine Thiolactone active pharmaceutical ingredient (API) or Dl-Homocysteine Thiolactone finished formulations upon request. The Dl-Homocysteine Thiolactone suppliers may include Dl-Homocysteine Thiolactone API manufacturers, exporters, distributors and traders.
Dl-Homocysteine Thiolactone Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Dl-Homocysteine Thiolactone GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Dl-Homocysteine Thiolactone GMP manufacturer or Dl-Homocysteine Thiolactone GMP API supplier for your needs.
A Dl-Homocysteine Thiolactone CoA (Certificate of Analysis) is a formal document that attests to Dl-Homocysteine Thiolactone's compliance with Dl-Homocysteine Thiolactone specifications and serves as a tool for batch-level quality control.
Dl-Homocysteine Thiolactone CoA mostly includes findings from lab analyses of a specific batch. For each Dl-Homocysteine Thiolactone CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Dl-Homocysteine Thiolactone may be tested according to a variety of international standards, such as European Pharmacopoeia (Dl-Homocysteine Thiolactone EP), Dl-Homocysteine Thiolactone JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Dl-Homocysteine Thiolactone USP).
